SynAct Pharma AB (FRA:8F8)
1.814
+0.012 (0.67%)
At close: Dec 4, 2025
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of €100.02 million as of December 5, 2025. Its market cap has increased by 226.19% in one year.
Market Cap
100.02M
Enterprise Value
93.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.81
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 6.72M to 100.02M, an increase of 1,387.90%. That is a compound annual growth rate of 33.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |